Ovoca Bio plc (AIM:OVB)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.150
-0.125 (-9.80%)
May 6, 2025, 11:10 AM GMT+1
27.78%
Market Cap937.98K
Revenue (ttm)n/a
Net Income (ttm)-616.92K
Shares Out81.56M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,276,823
Average Volume8,666
Open1.150
Previous Close1.275
Day's Range1.150 - 1.150
52-Week Range0.012 - 1.980
Beta0.63
RSI0.85
Earnings DateJun 25, 2025

About Ovoca Bio

Ovoca Bio plc, a clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health. It’s lead product is Orenetide, a novel synthetic peptide for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1985
Employees 1
Stock Exchange London Stock Exchange AIM
Ticker Symbol OVB
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.